Evidence map›Paper›PMID 41645203›Full record

ArticleJournal of nanobiotechnology2026

Dual-responsive semiconducting oligomer/doxorubicin nanoplatform for photoacoustic imaging-guided synergistic chemo-photothermal therapy.

Wei Du, Baoxin Wang, Jie Qiu, Weijun Fang, Haoxue Li, Jin Zhang, Rui Liu, Yingzhong Zhu, Hui Wang, Qiong Wu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wei Du *School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Baoxin Wang *School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Jie QiuSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Weijun FangSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Haoxue LiThe First Clinical Medical College, Anhui Medical University, Hefei, 230032, China.
Jin ZhangTechnical Center of Xiamen Customs, Xiamen, 361001, China.
Rui LiuSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Yingzhong ZhuSchool of Materials Science and Chemical Engineering, Chuzhou University, Chuzhou, 239000, China.
Hui WangSchool of Pharmacy, Wannan Medical College, Wuhu, 241002, China.
Qiong WuState Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), School of Flexible Electronics (Future Technologies), Nanjing Tech University (NanjingTech), Nanjing, 211816, China. iamqwu@njtech.edu.cn.
Tingting ZhaoSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China. ttzhao@ahmu.edu.cn.

Funding

the National Natural Science Foundation of China 22474004
6 · The paper itself

Abstract

Effective image-guided and precisely controlled drug release remains a critical challenge in cancer therapy, particularly for overcoming drug resistance and minimizing systemic toxicity. Herein, we developed a multifunctional nanoplatform by co-encapsulating a newly engineered near-infrared (NIR)-absorbing semiconducting oligomer (TD19) and doxorubicin (DOX) into DSPE-PEG

Indexed as

DoxorubicinNanoparticlesPhotoacoustic TechniquesPhotothermal TherapyAnimalsApoptosisCell Line, TumorDrug CarriersDrug LiberationFemaleHumansMiceMice, Inbred BALB CMice, NudePhosphatidylethanolaminesPolyethylene GlycolsDoxorubicinDrug CarriersPhosphatidylethanolaminesPolyethylene GlycolsCo-delivery drugsControllable release drugsNear-infrared regionPhotoacoustic imagingPhotothermal therapy

Identifiers

PMID41645203
PMCPMC12964734

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.